Retraction
for Rao et al.,
J Clin Endocrinol Metab
91 (1) 159-168.
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 6 2118
Copyright © 2006 by The Endocrine Society
Announcement and Resource |
Statement of Retraction
After a careful examination of the paper by A. S. Rao, N. Kremenevskaja, R. von Wasielewski, V. Jakubcakova, S. Kant, J. Resch, and G. Brabant titled "Wnt/ß-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer"
[J Clin Endocrinol Metab 2006 Jan.; 91(1):159168 (Epub 2005 Nov. 1)], the authors have realized that serious errors were made. Therefore, the authors have requested retraction of the article, along with an apology to the readers that the errors were not caught earlier.